http://www.who.int/medicines/publications/essentialmedicines/en/index.html

Henry D, Lim LL, Garcia Rodriguez LA, et al. Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis. BMJ 1996;312(7046):1563-6.

Hochberg MC, Altman RD, April KT, et al. on behalf of the American College of Rheumatology. American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee. Arthritis Care Res (Hoboken) 2012;64(4):455-74.

Minghetti P, Casiraghi A, Cilurzo F, et al. Evaluation of adhesive properties of transdermal therapeutic systems containing nitroglycerin. Boll Chim Farm. 2001;140(2):63-7.

Moore RA, Tramèr MR, Carroll D, et al. Quantitative systematic review of topically applied non-steroidal anti-inflammatory drugs. BMJ 1998;316(7128):333-8.

Pozzi AC. Disturbi articolari, peri-articolari ed extra-articolari causati da patologie infiammatorie e di natura reumatica: un nuovo cerotto medicato a base di ibuprofene. Select Selezione di clinica e terapia n.7 Anno 2012

Saino V, Monti D, Burgalassi S, et al. Optimization of skin permeation and distribution of ibuprofen by using nanostructures (coagels) based on alkyl vitamin C derivatives. Eur J Pharm Biopharm. 2010;76(3):443-9.

Tossicità gastrointestinale da FANS: quali strategie preventive per ridurla? AIFABollettino di Informazione sui Farmaci 2008; XV(1):18-23.